Bronchiolitis in COVID-19 times: a nearly absent disease?


Journal

European journal of pediatrics
ISSN: 1432-1076
Titre abrégé: Eur J Pediatr
Pays: Germany
ID NLM: 7603873

Informations de publication

Date de publication:
Jun 2021
Historique:
received: 29 12 2020
accepted: 26 01 2021
revised: 21 01 2021
pubmed: 1 2 2021
medline: 24 6 2021
entrez: 31 1 2021
Statut: ppublish

Résumé

Stay-at-home orders, physical distancing, face masks and other non-pharmaceutical interventions (NPIs) do not only impact COVID-19, but also the dynamics of various other infectious diseases. Bronchiolitis is a clinically diagnosed viral infection of the lower respiratory tract, and causes a yearly seasonal wave of admissions in paediatric wards worldwide. We counted 92,5% less bronchiolitis hospitalisations in Antwerp before the expected end of the peak this year (of which only 1 RSV positive), as compared to the last 3 years. Furthermore, there was a >99% reduction in the number of registered RSV cases in Belgium.Conslusion: The 2020 winter bronchiolitis peak is hitherto nonexistent, but we fear a 'delayed' spring/summer bronchiolitis peak when most NPIs will be relaxed and pre-pandemic life restarts. What is known? • Bronchiolitis causes a yearly seasonal wave of admissions in paediatric departments worldwide. • Non-pharmaceutical interventions (NPIs) do not only impact COVID-19, but also the dynamics of various other infectious diseases. What is new? • The 2020 winter bronchiolitis peak is hitherto nonexistent. • A 'delayed' spring or summer bronchiolitis peak could happen when most NPIs will be relaxed and pre-pandemic life restarts.

Identifiants

pubmed: 33517482
doi: 10.1007/s00431-021-03968-6
pii: 10.1007/s00431-021-03968-6
pmc: PMC7847293
doi:

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

1969-1973

Commentaires et corrections

Type : CommentIn

Références

J Infect. 2021 Jan;82(1):1-35
pubmed: 33278399
Am J Trop Med Hyg. 2020 Aug;103(2):564-569
pubmed: 32484156
Clin Infect Dis. 2021 Jun 15;72(12):2071-2075
pubmed: 32986818
Lancet. 2017 Jan 14;389(10065):211-224
pubmed: 27549684
Arch Argent Pediatr. 2020 Jun;118(3):222-223
pubmed: 32470281
Clin Infect Dis. 2021 Jun 15;72(12):2199-2202
pubmed: 32986804
Lancet. 2020 Nov 21;396(10263):1633-1634
pubmed: 33228919
Clin Infect Dis. 2021 Jan 27;72(2):319-322
pubmed: 33501967
Eur J Pediatr. 2020 Aug;179(8):1179-1180
pubmed: 32495145
Eur J Pediatr. 2020 Aug;179(8):1175-1177
pubmed: 32361966
Appl Environ Microbiol. 2007 Mar;73(6):1687-96
pubmed: 17220247

Auteurs

Daan Van Brusselen (D)

Department of Paediatric Infectious Diseases, GZA Hospitals, Antwerp, Belgium. daan.vanbrusselen@gza.be.
Multidisciplinary Unit of Infectious Diseases, GZA Hospitals, Antwerp, Belgium. daan.vanbrusselen@gza.be.
Department of Public Health & Primary Care, Ghent University, Ghent, Belgium. daan.vanbrusselen@gza.be.

Katrien De Troeyer (K)

Department of Public Health and Primary Care, University of Leuven, Ghent, Belgium.

Eva Ter Haar (E)

Division of Paediatric Pulmonology, ZNA Jan Palfijn Hospital, Antwerp, Belgium.

Ann Vander Auwera (A)

Department of Paediatric Infectious Diseases, GZA Hospitals, Antwerp, Belgium.

Katleen Poschet (K)

Department of Paediatric Infectious Diseases, GZA Hospitals, Antwerp, Belgium.

Sascha Van Nuijs (S)

Department of Paediatric Infectious Diseases, GZA Hospitals, Antwerp, Belgium.

An Bael (A)

Department of Paediatrics, ZNA Queen Paola Children's Hospital, Antwerp, Belgium.
Faculty of Medicine, Antwerp University, Antwerp, Belgium.

Kim Stobbelaar (K)

Division of Paediatric Pulmonology, Department of Paediatrics, University Hospital Antwerp, Edegem, Belgium.
Lab of Experimental Medicine and Pediatrics, Faculty of Medicine and Health Sciences, University of Antwerp, Antwerp, Belgium.

Stijn Verhulst (S)

Division of Paediatric Pulmonology, Department of Paediatrics, University Hospital Antwerp, Edegem, Belgium.
Lab of Experimental Medicine and Pediatrics, Faculty of Medicine and Health Sciences, University of Antwerp, Antwerp, Belgium.

Bruno Van Herendael (B)

Multidisciplinary Unit of Infectious Diseases, GZA Hospitals, Antwerp, Belgium.
Department of Microbiology, GZA Hospitals, Antwerp, Belgium.

Philippe Willems (P)

Multidisciplinary Unit of Infectious Diseases, GZA Hospitals, Antwerp, Belgium.
Department of Microbiology, GZA Hospitals, Antwerp, Belgium.

Melissa Vermeulen (M)

Scientific Directorate of Epidemiology and Public Health, Sciensano, Brussels, Belgium.

Jeroen De Man (J)

Department of Family Medicine and Population Health, University of Antwerp, Antwerp, Belgium.

Nathalie Bossuyt (N)

Scientific Directorate of Epidemiology and Public Health, Sciensano, Brussels, Belgium.

Koen Vanden Driessche (K)

Division of Paediatric Pulmonology, Department of Paediatrics, University Hospital Antwerp, Edegem, Belgium.
Section Paediatric Infectious Diseases, Laboratory of Medical Immunology, Radboud Centre for Infectious Diseases, Radboud Institute for Life Sciences, Nijmegen, The Netherlands.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH